GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) » Definitions » Total Stockholders Equity

Shanghai Bio-heart Biological Technology Co (HKSE:02185) Total Stockholders Equity : HK$777.89 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Bio-heart Biological Technology Co Total Stockholders Equity?

Shanghai Bio-heart Biological Technology Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was HK$777.89 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shanghai Bio-heart Biological Technology Co's Book Value per Share for the quarter that ended in Jun. 2024 was HK$3.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shanghai Bio-heart Biological Technology Co's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.00.

Shanghai Bio-heart Biological Technology Co Total Stockholders Equity Historical Data

The historical data trend for Shanghai Bio-heart Biological Technology Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Bio-heart Biological Technology Co Total Stockholders Equity Chart

Shanghai Bio-heart Biological Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
42.44 829.91 1,219.19 986.30 818.60

Shanghai Bio-heart Biological Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,132.80 986.30 902.89 818.60 777.89

Shanghai Bio-heart Biological Technology Co  (HKSE:02185) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shanghai Bio-heart Biological Technology Co's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(777.891-0)/243.417
=3.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shanghai Bio-heart Biological Technology Co's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.896 + 0.172) / 777.891
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Bio-heart Biological Technology Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shanghai Bio-heart Biological Technology Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Bio-heart Biological Technology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) » Definitions » Total Stockholders Equity
Comparable Companies
HKSE:06628 HKSE:02197 HKSE:00690 HKSE:09939 HKSE:02257 HKSE:02898 HKSE:02511 HKSE:01244 HKSE:08158 HKSE:01228 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
No.590 Ruiqing Road, Room 302, 3rd Floor, Building 4 & Building 6, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Website
http://www.bio-heart.com
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension.
Executives
Tpg Operating Group Ii, L.p. 2201 Interest of corporation controlled by you
Chen Hao 2201 Interest of corporation controlled by you
Zhu Linan 2201 Interest of corporation controlled by you
Wang Nengguang 2201 Interest of corporation controlled by you
Union Season Holdings Limited 2201 Interest of corporation controlled by you
Sk China Company Limited 2201 Interest of corporation controlled by you
Right Lane Limited 2201 Interest of corporation controlled by you
Proud Solar Limited 2201 Interest of corporation controlled by you
Magic Grace Limited 2101 Beneficial owner
Loft Success Investments Limited 2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii, L.p. 2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii Gp Limited 2201 Interest of corporation controlled by you
Lc Fund Gp Limited 2201 Interest of corporation controlled by you
Great Unity Fund I, L.p. 2201 Interest of corporation controlled by you
Lian Xiang Kong Gu Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

Shanghai Bio-heart Biological Technology Co Headlines

No Headlines